| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $16.3B | $14.0B | $14.9B | $14.0B | $2.9B | $2.4B | $2.5B |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | $2.2B | $2.0B | $2.0B | $1.9B | $1.8B | $1.7B | $1.4B |
| Operating Income | — | — | — | — | — | — | — |
| Net Income | $2.3B | $1.6B | $1.3B | $1.2B | $2.2B | $1.1B | $1.6B |
| EPS (Basic) | $4.97 | $3.14 | $2.34 | $2.13 | $0.44 | $0.20 | — |
| EPS (Diluted) | $4.91 | $3.13 | $2.33 | $2.11 | $0.43 | $0.20 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $23.2B | $22.0B | $21.9B | $22.2B | $22.9B | $21.8B | $19.5B |
| Current Assets | $8.4B | $7.5B | $7.3B | $8.3B | $8.7B | $7.5B | $6.5B |
| Cash & Equivalents | — | — | — | — | — | — | — |
| Total Liabilities | — | — | — | — | — | — | — |
| Current Liabilities | $2.9B | $3.0B | $3.8B | $2.3B | $3.0B | $1.9B | $1.7B |
| Stockholders' Equity | $12.0B | $10.7B | $10.4B | $11.3B | $11.1B | $10.1B | $9.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.3B | $1.8B | $1.8B | $1.9B | $2.6B | $2.4B | $2.5B |
| Investing Cash Flow | $-0.5B | $-0.5B | $-0.4B | $-0.5B | $-0.5B | $-1.1B | $-0.6B |
| Capital Expenditures | $0.3B | $0.3B | $0.4B | $0.3B | $0.5B | $0.4B | $0.2B |
| Financing Cash Flow | $-1.8B | $-1.3B | $-2.3B | $-2.1B | $-0.9B | $0.1B | $-1.2B |